Comienzos
keyboard_arrow_right
keyboard_arrow_right
According to a study published in todays issue of the Annals of Family Medicine.
Reports

According to a study published in todays issue of the Annals of Family Medicine.

PENN Medicine is certainly a $3.5 billion enterprise focused on the related missions of medical education, biomedical research, and excellence in patient care. PENN Medicine includes the University of Pennsylvania College of Medicine and the University of Pennsylvania Health System. Penn’s College of Medicine is rated #2 in the nation for receipt of NIH analysis money; and rated #3 in the nation in U.S. Information & World Report’s latest ranking of top research-oriented medical colleges. Supporting 1,400 faculty and 700 college students fulltime, the School of Medication is recognized worldwide for its excellent education and training of the next generation of physician-scientists and leaders of academic medicine.Unfortunately, intravenous iron might promote bacterial growth and impair the disease fighting capability, and treated patients face an increased risk of infection. No large studies have looked at how different iron dosing regimens may impact this risk. Related StoriesNew $6.7 million project aims to help kidney dialysis individuals live longerCirculating protein predicts threat of chronic kidney diseaseAdvances in nanofilter technology may result in surgically implantable, artificial kidney To research, Maurice Alan Brookhart, PhD and his co-workers assessed the security of commonly used intravenous iron dosing practices in dialysis patients with respect to infection risk. In particular, they compared the protection of providing a great deal of iron over a short period of time vs providing smaller, less frequent administrations .